Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: rfan Khan / Los Angeles Times via Getty Images

The benefits of the Johnson & Johnson coronavirus vaccine outweigh any potential risks, according to the Centers for Disease Control and Prevention.

The big picture: There have been 7.8 cases of Guillain-Barre syndrome, a rare neurological disorder, per million doses among adults, which is higher than expected in the general population, according to CDC data.

  • By comparison, there has been about one case of Guillain-Barre per million doses for people who received either of the two-dose mRNA vaccines, according to the agency.
  • The data comes a little over a week after the Food and Drug Administration added a warning to the Johnson & Johnson coronavirus vaccine, saying the shot can lead to an increased risk of a rare neurological condition.

Driving the news: Despite the small risk of an adverse reaction to the shot, the Johnson & Johnson vaccine prevents against the vast majority of death and serious illness from coronavirus.

  • "Many hospitalizations, ICU admissions and deaths can be prevented through Janssen and mRNA Covid-19 vaccines, far outweighing the risks," CDC researcher Dr. Hannah Rosenblum told the agency's Advisory Committee on Immunization Practices in a meeting on Thursday, per CNN.

Between the lines: The CDC data show that for women ages 18 to 29, the vaccine would prevent 8,900 cases of coronavirus and five COVID-19 deaths and only one GBS case might occur.

  • For men in that age group, 6,600 COVID-19 cases and three COVID-19 deaths would be prevented and only two GBS cases might occur.
  • For every million doses administered among women ages 30 to 49, the data suggest 10,100 COVID-19 cases and 20 COVID-19 deaths could be prevented compared with the risk of about six to seven GBS cases.
  • For men in that age group, 7,600 COVID-19 cases and 25 COVID-19 deaths could be prevented compared with the risk of about seven to eight GBS cases.
  • For every million doses administered among women ages 50 to 64, the data suggest 12,100 COVID-19 cases and 120 COVID-19 deaths could be prevented compared with the risk of seven to eight GBS cases.
  • Among men, the vaccine would prevent about 10,100 Covid-19 cases and 140 Covid-19 deaths and come with the risk of between 14 to 17 GBS cases, according to the CDC data.

Go deeper

Sep 22, 2021 - Health

FDA approves Pfizer boosters for high-risk individuals, people 65 and up

Photo: Paul Hennessy/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Wednesday approved Pfizer-BioNTech coronavirus booster shots for people at high risk of severe COVID-19 and people 65 years and older.

Driving the news: The approval comes just days after an FDA advisory panel recommended boosters for the two groups but overwhelmingly voted against the third shots for younger Americans.

Sep 23, 2021 - Health

Asymptomatic Florida students exposed to COVID no longer have to quarantine

Gov. Ron DeSantis during a September news conference in Viera, Florida. Photo: Paul Hennessy/SOPA Images/LightRocket via Getty Images

Florida Gov. Ron DeSantis announced Wednesday an emergency order allowing parents to decide whether their children should quarantine or stay in school if they're exposed to COVID-19, provided they're asymptomatic.

Why it matters: People infected with COVID-19 can spread the coronavirus starting from two days before they display symptoms, according to the CDC. Quarantine helps prevent the virus' spread.

Mormon Church to mandate masks in temples

The San Diego California Temple in La Jolla, California. Photo: RBL/Bauer-Griffin/GC Images via Getty Images

The Church of Jesus Christ of Latter-day Saints told its members on Wednesday that all patrons and workers will be required to wear face masks at all times while in the temple.

Why it matters: It's the Mormon Church's latest effort to encourage masking and vaccination among its over 16.6 million members around the world.